We Believe the Only Acceptable Number for Sepsis Misdiagnosis is Zero
Every false-positive blood culture could result in patient harm.
The Cost of Blood Culture Contamination
Blood culture contamination and false-positive results for sepsis routinely lead to unnecessary and prolonged use of broad-spectrum antibiotics, which can have harmful clinical and cost consequences. 2
3 million antibiotic-resistant and Clostridioides difficile Infection (CDI) each year and 48,000 people die.
1 in 5 patient experience adverse drug event (ADE) associated with antibiotic administration in acute care hospital setting.
$6 billion is spent by our U.S. healthcare system each year on unnecessary treatment associated with false-positive blood culture results. 49
This does not include the impact blood culture contamination can have on CMS key quality outcome metrics and hospital reimbursement.
Developed by Physicians. Backed by Science. Proven Results.
The Steripath® Initial Diversion Device® is the only FDA 510(k)-cleared device platform specifically indicated to reduce blood culture contamination 3 for sepsis testing accuracy. Created by physicians, pathologists, clinical microbiologists and laboratorians, Steripath is the simple, all-in-one, evidence-backed solution that gives you the proven results you need for diagnostic stewardship to provide your patients with the best quality care.
Trusted by Hospitals & Healthcare Systems Nationwide
Clinical Infectious Diseases
Reduction in blood culture contamination through use of Initial Specimen Diversion Device
Journal for Emergency Nursing
Effectiveness of a novel specimen collection system in reducing blood culture contamination rates
Journal of Hospital Infection
Initial Specimen Diversion Device® reduces blood culture contamination and vancomycin use in academic medical center
American Journal of Medical Quality
Initial Specimen Diversion Device® utilization mitigates blood culture contamination across regional community hospital and acute care facility